12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks showed significant movement. Avalo Therapeutics led the gainers with a 328.2% increase, while NuCana experienced the largest drop among the losers, declining by 19.8%. Other notable movers include Xilio Therapeutics with a 223.94% increase and Akanda with a 27.1% rise. On the downside, Yield10 Bioscience and Sonoma Pharmaceuticals saw declines of 10.51% and 10.48%, respectively.
March 28, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NuCana stock declined by 19.8% to $0.25, with a market value of their outstanding shares at $13.0 million.
The decline in NuCana's stock price suggests negative sentiment or disappointing news related to the company. This could lead to decreased investor confidence and further declines in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Avalo Therapeutics shares surged 328.2% to $20.34, with a market cap of $16.3 million.
The significant surge in Avalo Therapeutics' stock price indicates strong investor interest, likely due to positive news or developments related to the company. This could lead to increased trading volume and potentially more gains in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Xilio Therapeutics stock moved upwards by 223.94% to $2.07, with a market value of $56.9 million.
Xilio Therapeutics' significant price increase suggests positive developments or investor optimism about the company's future. This could result in continued interest and potential short-term gains.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100